BAMCO Inc
TMO icon

BAMCO Inc’s Thermo Fisher Scientific TMO Stock Holding History

BAMCO Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Sell
9,219
-14,451
-61% -$6.94M 0.01% 262
2026
Q1 		$11.6M Sell
23,670
-5,150
-18% -$2.79M 0.04% 223
2025
Q4 		$16.7M Buy
28,820
+4,108
+17% +$2.32M 0.05% 209
2025
Q3 		$12M Sell
24,712
-6,054
-20% -$2.82M 0.03% 228
2025
Q2 		$12.5M Sell
30,766
-6,869
-18% -$2.87M 0.03% 216
2025
Q1 		$18.7M Sell
37,635
-4,000
-10% -$2.17M 0.06% 205
2024
Q4 		$21.7M Hold
41,635
– – 0.06% 198
2024
Q3 		$25.8M Buy
41,635
+498
+1% +$295K 0.07% 187
2024
Q2 		$22.7M Buy
41,137
+6,727
+20% +$3.85M 0.07% 194
2024
Q1 		$20M Buy
34,410
+5,672
+20% +$3.18M 0.05% 210
2023
Q4 		$15.3M Buy
28,738
+5,578
+24% +$2.7M 0.04% 214
2023
Q3 		$11.7M Buy
23,160
+1,101
+5% +$587K 0.03% 227
2023
Q2 		$11.5M Buy
22,059
+589
+3% +$318K 0.03% 230
2023
Q1 		$12.4M Buy
21,470
+1,857
+9% +$1.05M 0.04% 225
2022
Q4 		$10.8M Sell
19,613
-1,297
-6% -$687K 0.04% 227
2022
Q3 		$10.6M Sell
20,910
-1,153
-5% -$645K 0.03% 234
2022
Q2 		$12M Sell
22,063
-112
-0.5% -$61.6K 0.04% 236
2022
Q1 		$13.1M Buy
22,175
+581
+3% +$334K 0.03% 259
2021
Q4 		$14.4M Buy
21,594
+3,194
+17% +$1.99M 0.03% 276
2021
Q3 		$10.5M Buy
18,400
+5,441
+42% +$2.99M 0.02% 299
2021
Q2 		$6.54M Buy
12,959
+300
+2% +$142K 0.02% 321
2021
Q1 		$5.78M Buy
12,659
+5,700
+82% +$2.72M 0.01% 315
2020
Q4 		$3.24M Buy
6,959
+2,948
+73% +$1.38M 0.01% 310
2020
Q3 		$1.77M Buy
4,011
+406
+11% +$168K 0.01% 294
2020
Q2 		$1.31M Buy
3,605
+625
+21% +$209K ﹤0.01% 278
2020
Q1 		$845K Buy
2,980
+299
+11% +$94.3K ﹤0.01% 278
2019
Q4 		$871K Buy
2,681
+541
+25% +$164K ﹤0.01% 295
2019
Q3 		$623K Buy
+2,140
New +$613K ﹤0.01% 300

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BAMCO Inc's TMO Position: Q2 2026 in Review

BAMCO Inc reduced its Thermo Fisher Scientific (TMO) stake by 61% in Q2 2026, selling an estimated $6.94M and leaving 9,219 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #262.

BAMCO Inc first reported a position in TMO in Q3 2019 and has held it in 28 quarters since. The position peaked at $25.8M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BAMCO Inc held 9,219 shares of Thermo Fisher Scientific worth $4.62M as of Q2 2026.
  • BAMCO Inc sold 14,451 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.94M.
  • Thermo Fisher Scientific made up 0.01% of BAMCO Inc's portfolio in Q2 2026, its #262 holding.
  • BAMCO Inc first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 28 quarters since.
  • BAMCO Inc's Thermo Fisher Scientific position peaked at $25.8M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.